CytomX Therapeutics, Inc. (CTMX)

4.395 -0.12 (-2.77%) USD  |  NASDAQ  |  Mar 30, 16:00
4.35 -0.04 (-1.02%) After-Hours: 18:03
More

CytomX Therapeutics Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for CTMX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade